Clin2
NCT07521748Likely a fitNot yet recruiting

Safety study of RC017 eye ointment in healthy adults

Dry Eye

Part of Eyes & vision clinical trials.

This early-stage study tests a new eye ointment called RC017 to see how safe it is and how the body handles it. Healthy volunteers will apply the ointment to their eyes once or multiple times so researchers can check for any side effects.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
24 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • Be between 18 and 55 years old and in generally good health
  • Have healthy eyes with no history of eye disease, infection, or eye surgery
  • Not have worn contact lenses in the 2 weeks before screening, and not plan to wear them during the study
  • Not be taking any prescription medications, over-the-counter drugs, vitamins, or eye drops for 2 weeks before screening
  • Have no significant medical history (heart, kidney, liver, nerve, or mental health conditions)
  • Not smoke more than 5 cigarettes per day, drink heavily, or use recreational drugs

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07625124Not yet recruiting· Phase 2
Testing a new eye drop for dry eye disease

This study tests whether RCI001, a new eye drop treatment, can help people with dry eye disease. If you've had dry eye symptoms for at least 6 months and are interested in trying a new treatment, this trial may be for you.

NCT07740564Not yet recruiting· Phase 3
Study of OT202 eye drops for moderate to severe dry eye

This study tests an eye drop called OT202 for people with moderate to severe dry eye. It aims to see if it can help reduce dryness and improve eye comfort.

Bengbu, Anhui
NCT06379685Not yet recruiting· Phase 1
Testing new eye drops for safety and comfort

This study tests a new eye drop (PRO-190) against a common artificial tear (Systane Ultra) to see how safe and comfortable it is. Healthy volunteers will use the drops and be monitored for any side effects or changes in their eyes.

NCT07245017Recruiting· Early Phase 1
Testing JN002 drops for dry eye disease

This trial tests whether a new eye drop, JN002, can help people with dry eye disease. It checks if the drops improve symptoms and eye health over time.

Shanghai
NCT07614347Not yet recruiting
Testing a New Eye Scan System for Dry Eye Diagnosis

This study evaluates a new computer-assisted imaging system that uses specialized microscopy to help diagnose dry eye disease. Researchers need both healthy volunteers and people with dry eye symptoms to test how well the system works.

NCT07313722Recruiting· Phase 1
Testing a new eye drop for safety in healthy volunteers

This trial tests whether a new eye drop called BT01001 is safe for healthy adults. You may join if you have good overall and eye health, and do not use contact lenses or have chronic eye problems.

Shanghai

Hear when a new Dry Eye trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.